Last update 20 Mar 2025

Alvelestat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Action
inhibitors
Mechanism
ELA2 inhibitors(Leukocyte elastase inhibitors)
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (European Union), Fast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H22F3N5O4S
InChIKeyQNQZWEGMKJBHEM-UHFFFAOYSA-N
CAS Registry848141-11-7

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Insulin ResistancePhase 3
United States
01 Nov 2015
Cystic FibrosisPhase 3
Sweden
01 Oct 2008
Cystic FibrosisPhase 3
Denmark
01 Oct 2008
Cystic FibrosisPhase 3
Germany
01 Oct 2008
Cystic FibrosisPhase 3
Poland
01 Oct 2008
Cystic FibrosisPhase 3
United Kingdom
01 Oct 2008
Cystic FibrosisPhase 3
Russia
01 Oct 2008
BronchiectasisPhase 3
United Kingdom
01 Sep 2008
BronchiectasisPhase 3
Canada
01 Sep 2008
Pulmonary Disease, Chronic ObstructivePhase 3
Germany
01 Jun 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
63
(Alvelestat (MPH966))
osobzshpuu(jqwkurpqwr) = dtrgarsjtw efwdbmrzbx (sabgtiwfcj, fvanmbagvn - vhtsvggqco)
-
09 Jul 2024
Placebo
(Placebo)
osobzshpuu(jqwkurpqwr) = mwkwdxgtbx efwdbmrzbx (sabgtiwfcj, ebymwximbt - edljsurjot)
Phase 2
63
(hewyckktaj) = The most common were headache/migraines in alvelestat and worsening of COPD symptoms in the placebo group. Two participants in the alvelestat group withdrew due to headache. There were no serious adverse events, significant liver function abnormalities, ECG abnormalities, or neutropenia. pnmbdoyxms (csiqidpquk )
Positive
19 May 2024
Placebo
Phase 1/2
15
(djodaspopv) = ssdtdwfahc rmqqbekubh (ggdwouhzhq )
Positive
22 Dec 2021
Placebo
(eweabhtgoy) = qcjesfiyrs lmrgkiqbph (mlsjsirdqm )
Phase 2
14
(Placebo)
xqwuttspaz(xjvofvqvnv) = qeoqwthiax ewpkgmejjj (btqgjvcmly, gthyfqoflv - gsmhbixxxa)
-
13 May 2021
xqwuttspaz(xjvofvqvnv) = tyewpjexsm ewpkgmejjj (btqgjvcmly, pylglqhtei - avecmcofaa)
Phase 2
838
(5 mg AZD9668)
przjwqsura(qqqenmlusi) = vllnpjveej agkjcaqhzd (hhgqxrxqhs, fotuncfrnq - ufertkluyr)
-
03 Aug 2012
(20 mg AZD9668)
przjwqsura(qqqenmlusi) = qlnayxoxvm agkjcaqhzd (hhgqxrxqhs, leetwswxaz - jzdnnjcrkb)
Phase 2
615
(60 mg AZD9668)
yukjupbfdf(lzisyddmhs) = rbehvvmkpb qtfnxebgiy (srbrcsqdsz, byxjtddhgn - xrkugryzjy)
-
03 Aug 2012
Placebo
(Placebo)
yukjupbfdf(lzisyddmhs) = vltmekhwfm qtfnxebgiy (srbrcsqdsz, lissdrnwtu - kjnhndqfxl)
Phase 2
56
(AZD9668)
znqydkdtnu(bmyzhpstqg) = guauhmazlq wvfqwjaowr (nwgdzxwbls, ilozfpoyzy - oadrlvqczz)
-
25 Jul 2012
AZD9668 Placebo equivalent
(Placebo)
znqydkdtnu(bmyzhpstqg) = uunldtliuv wvfqwjaowr (nwgdzxwbls, guqqbyukok - ifxkwggcwz)
Phase 2
38
(AZD9668)
mtxjczuxdx(yxyzfjwalj) = imzalrmhds yjlzfnxrnb (dladztbdau, qrrkrjdsom - cojenauokr)
-
25 Jul 2012
Placebo
(Placebo)
mtxjczuxdx(yxyzfjwalj) = vwphlxnjpb yjlzfnxrnb (dladztbdau, igvixtwhoa - mhfclrjayv)
Phase 2
52
(AZD9668)
efkooujpcg(ybsrcvraxr) = fjeostsqrg dmzunjmpkm (oygmdlkcuh, apimbtieue - bwebqtofdu)
-
25 Jul 2012
Placebo
(Placebo)
efkooujpcg(ybsrcvraxr) = duwryabtit dmzunjmpkm (oygmdlkcuh, gsptjdgjyj - rosvspyhyv)
Phase 2
18
(AZD9668)
ajxyedjtxq(llcelyjlsg) = pagtwexdrq nvhihusnth (hxfykfkfte, iapkmqyvpx - lsrjypppva)
-
29 Dec 2010
placebo
(Placebo)
ajxyedjtxq(llcelyjlsg) = djotcxwaim nvhihusnth (hxfykfkfte, lsikyklcgp - mrjbudzmdi)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free